AEMD - Aethlon Medical, Inc. Stock Analysis

Stock Taper

SCREENER COMPARE ANY 2 STOCKS

AEMD

AETHLON MEDICAL, INC.

NASDAQ

$1.53

▼ DOWN 1.92% (-0.03)

KEY STATISTICS

Market Cap$821.67 K

52w High$41.50

52w Low$1.52

Dividend Yield—

Frequency—

P/E-0.11

Volume102.96K

Shares Out.526.71K

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

James Frakes

COMPENSATION 2026

Salary$500,000

Stock Awards$0

Incentive Plan Pay$0

All Other Comp.$326,922

Total$826,922

ABOUT

SECTOR

Healthcare

WENT PUBLIC

March 4, 1999

METHOD OF GOING PUBLIC

IPO

FULL TIME EMPLOYEES

PRICE TARGET

Target High$1.50

Target Low$1.50

Target Median$1.50

Target Consensus$1.50

UPCOMING EARNINGS

DateNov 11, 2026

DayWednesday

Rev. Est.—

NOV

WED

SPLIT RECORD

DATE	TYPE	RATIO
2026-08-04	Reverse	1:5
2025-10-20	Reverse	1:10
2025-06-09	Reverse	1:8
2023-10-05	Reverse	1:10
2019-10-15	Reverse	1:15
2015-04-14	Reverse	1:50

PRICE

$1.53 ▼ DOWN 1.92% (−$0.03)

OVERLAYS

About Aethlon Medical, Inc.

https://www.aethlonmedical.com ↗

Aethlon Medical, Inc. develops innovative medical devices like the Hemopurifier to diagnose and treat serious diseases, including viruses like COVID-19, through collaborations such as with UPMC Hillman Cancer Center.

INDUSTRY

Medical - Devices

A PRODUCT AETHLON MEDICAL, INC. IS KNOWN FOR

Aethlon Hemopurifier®

The Aethlon Hemopurifier® is a FDA-designated breakthrough medical device that filters harmful viruses and exosomes from blood, aiming to treat cancer and severe viral infections.

COMPETITORS

COMPETITOR

Revenue by Products

Icon	PRODUCT	Q1-2022	Q2-2022	Q3-2022	Q4-2022
	Aethlon	$131.97K	$263.93K ▲	$281.05K ▲	$13.12K ▼
	E S I	—	—	—	$0

Revenue by Geography

REGION	Q2-2013	Q3-2013	Q3-2015
Eighth Milestone	$216.75K	—	—
MileStoneMTwo	—	$216.75K	—
MileStoneTwoPointTwoPointTwoPointThree	—	$216.75K	—
MileStoneTwoPointThreePointThreePointOne	—	$208.78K	—
MileStoneTwoPointTwoPointOnePointFour	—	$183.37K	—
Seventh Milestone	$183.37K	—	—
Milestone M9	—	—	$0
Sixth Milestone	$216.75K	$0 ▼	—